GTS5:BRCA-related cancer predisposition syndrome (BRCA1, BRCA2): Difference between revisions
| [checked revision] | [checked revision] |
Kgeiersbach (talk | contribs) No edit summary |
Bailey.Glen (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
[[GTS5:Table_of_Contents|Genetic Tumour Syndromes (Who Classification, 5th ed.)]] | |||
==Primary Author(s)*== | ==Primary Author(s)*== | ||
<span style="color:#0070C0">Katherine Geiersbach, MD, Mayo Clinic - Rochester, MN, USA</span> | <span style="color:#0070C0">Katherine Geiersbach, MD, Mayo Clinic - Rochester, MN, USA</span> | ||
| Line 4: | Line 5: | ||
<span style="color:#0070C0"> </span> | <span style="color:#0070C0"> </span> | ||
==WHO Classification of Disease== | ==WHO Classification of Disease== | ||
{| class="wikitable" | {| class="wikitable" | ||
!Structure | !Structure | ||
| Line 10: | Line 11: | ||
|- | |- | ||
|Book | |Book | ||
| | |Genetic Tumour Syndromes (5th ed.) | ||
|- | |- | ||
|Category | |Category | ||
| | |DNA repair and genomic stability | ||
|- | |- | ||
|Family | |Family | ||
| | |Homologous recombination | ||
|- | |- | ||
|Type | |Type | ||
| | |BRCA-related cancer predisposition syndrome (BRCA1, BRCA2) | ||
|- | |- | ||
|Subtype(s) | |Subtype(s) | ||
| | |N/A | ||
|} | |} | ||
==Related Terminology== | ==Related Terminology== | ||
<span style="color:#0070C0">(''Instructions: This table will have the related terminology from the WHO book <u>autocompleted</u>.)''</span> | <span style="color:#0070C0">(''Instructions: This table will have the related terminology from the WHO book <u>autocompleted</u>.)''</span> | ||